Long-term successful liver-kidney transplantation in a child with atypical hemolytic uremic syndrome caused by homozygous factor H deficiency.
Gonzales, Emmanuel; Ulinski, Tim; Habes, Dalila; Deschênes, Georges; Frémeaux-Bacchi, Véronique; Bensman, Albert.
; 31(12): 2375-2378, 2016 12.
Artigo em Inglês | MEDLINE | ID: mdl-27744619
Favorable long-term outcomes of isolated liver transplantation in a child with atypical hemolytic uremic syndrome caused by a novel complement factor H mutationâ©.
Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation.
The clinical spectrum of hemolytic uremic syndrome secondary to complement factor H autoantibodies.
Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS.
Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab.
Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
A complicated case of atypical hemolytic uremic syndrome with frequent relapses under eculizumab.
Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
Trasplante renal exitoso con protocolo de eculizumab, timoglobulina y belatacept en paciente altamente sensibilizada con síndrome hemolítico urémico atípico por mutación del factor H
Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.